Cochrane Abstracts
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation: Cochrane systematic review
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Lamivudine or Adefovir Dipivoxil Alone or Combined With Immunoglobulin for Preventing Hepatitis B Recurrence After Liver Transplantation: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435284/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation:_Cochrane_systematic_review. Accessed 03 July 2022.
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435284/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation:_Cochrane_systematic_review. Accessed July 3, 2022.
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435284/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation:_Cochrane_systematic_review
Lamivudine or Adefovir Dipivoxil Alone or Combined With Immunoglobulin for Preventing Hepatitis B Recurrence After Liver Transplantation: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2022 July 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435284/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation: Cochrane systematic review
ID - 435284
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435284/all/Lamivudine_or_adefovir_dipivoxil_alone_or_combined_with_immunoglobulin_for_preventing_hepatitis_B_recurrence_after_liver_transplantation:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
